tin mesoporphyrin

DRUG6 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Research Resources (NCRR)

Conditions

Glucosephosphate Dehydrogenase DeficiencyHemolytic Disease of NewbornHyperbilirubinemiaPorphyria

Phase 1

Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

CompletedNCT00004397

National Center for Research Resources (NCRR)Porphyria

Start: 1998-01-31End: 2000-05-31Target: 20Updated: 2005-06-24

Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria

CompletedNCT00004398

National Center for Research Resources (NCRR)Porphyria

Start: 1998-01-31End: 2000-05-31Target: 24Updated: 2005-06-24

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

CompletedNCT00004789

National Center for Research Resources (NCRR)Porphyria

Start: 1993-07-31Target: 59Updated: 2005-06-24

Phase 2

Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns

CompletedNCT00004382

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Hyperbilirubinemia

Start: 1999-12-31Target: 80Updated: 2008-09-09

Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

CompletedNCT00004381

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Glucosephosphate Dehydrogenase Deficiency, Hemolytic Disease of Newborn, Hyperbilirubinemia

Start: 1999-12-31Updated: 2005-06-24

Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias

CompletedNCT00004396

National Center for Research Resources (NCRR)Porphyria

Start: 1997-09-30Target: 32Updated: 2005-06-24